210 related articles for article (PubMed ID: 27054329)
1. KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages.
Grimaldi A; D'Alessandro G; Golia MT; Grössinger EM; Di Angelantonio S; Ragozzino D; Santoro A; Esposito V; Wulff H; Catalano M; Limatola C
Cell Death Dis; 2016 Apr; 7(4):e2174. PubMed ID: 27054329
[TBL] [Abstract][Full Text] [Related]
2. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
D'Alessandro G; Catalano M; Sciaccaluga M; Chece G; Cipriani R; Rosito M; Grimaldi A; Lauro C; Cantore G; Santoro A; Fioretti B; Franciolini F; Wulff H; Limatola C
Cell Death Dis; 2013 Aug; 4(8):e773. PubMed ID: 23949222
[TBL] [Abstract][Full Text] [Related]
3. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
Bouhy D; Ghasemlou N; Lively S; Redensek A; Rathore KI; Schlichter LC; David S
J Neurosci; 2011 Nov; 31(45):16298-308. PubMed ID: 22072681
[TBL] [Abstract][Full Text] [Related]
5. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
[TBL] [Abstract][Full Text] [Related]
6. Crocin Improves the Endothelial Function Regulated by Kca3.1 Through ERK and Akt Signaling Pathways.
Yang H; Li X; Liu Y; Li X; Li X; Wu M; Lv X; Chunhua C; Ding X; Zhang Y
Cell Physiol Biochem; 2018; 46(2):765-780. PubMed ID: 29621746
[TBL] [Abstract][Full Text] [Related]
7. KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway.
Wei T; Wang Y; Xu W; Liu Y; Chen H; Yu Z
Neurobiol Dis; 2019 Dec; 132():104588. PubMed ID: 31470105
[TBL] [Abstract][Full Text] [Related]
8. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.
Chen YJ; Nguyen HM; Maezawa I; Grössinger EM; Garing AL; Köhler R; Jin LW; Wulff H
J Cereb Blood Flow Metab; 2016 Dec; 36(12):2146-2161. PubMed ID: 26661208
[TBL] [Abstract][Full Text] [Related]
9. Role of KCa3.1 Channels in Macrophage Polarization and Its Relevance in Atherosclerotic Plaque Instability.
Xu R; Li C; Wu Y; Shen L; Ma J; Qian J; Ge J
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):226-236. PubMed ID: 28062499
[TBL] [Abstract][Full Text] [Related]
10. K
Pang ZD; Wang Y; Wang XJ; She G; Ma XZ; Song Z; Zhao LM; Wang HF; Lai BC; Gou W; Du XJ; Deng XL
FASEB J; 2019 Dec; 33(12):14760-14771. PubMed ID: 31690106
[TBL] [Abstract][Full Text] [Related]
11. Ca
Cocozza G; di Castro MA; Carbonari L; Grimaldi A; Antonangeli F; Garofalo S; Porzia A; Madonna M; Mainiero F; Santoni A; Grassi F; Wulff H; D'Alessandro G; Limatola C
Brain Behav Immun; 2018 Oct; 73():584-595. PubMed ID: 29981425
[TBL] [Abstract][Full Text] [Related]
12. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
13. A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma.
Turner KL; Honasoge A; Robert SM; McFerrin MM; Sontheimer H
Glia; 2014 Jun; 62(6):971-81. PubMed ID: 24585442
[TBL] [Abstract][Full Text] [Related]
14. The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.
Chen YJ; Raman G; Bodendiek S; O'Donnell ME; Wulff H
J Cereb Blood Flow Metab; 2011 Dec; 31(12):2363-74. PubMed ID: 21750563
[TBL] [Abstract][Full Text] [Related]
15. Increased Interleukin-10 Expression by the Inhibition of Ca
Ohya S; Matsui M; Kajikuri J; Endo K; Kito H
J Pharmacol Exp Ther; 2021 Apr; 377(1):75-85. PubMed ID: 33504590
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
[TBL] [Abstract][Full Text] [Related]
18. Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors.
D'Alessandro G; Limatola C; Catalano M
Curr Neuropharmacol; 2018; 16(5):636-643. PubMed ID: 28707595
[TBL] [Abstract][Full Text] [Related]
19. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
Freise C; Querfeld U
Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]